Although recently strengthened immunosuppression protocols have decreased the incidence of clinical acute rejection of renal transplants, subclinical acute rejection and borderline changes remain problematic. This study was performed to evaluate the effects of antirejection therapies for early subclinical acute rejection and borderline changes.
Featured article: Effects of antirejection therapies for early subclinical acute rejection in renal transplant protocol biopsies
Featured article: Higher dental care is positively associated with key prognosis factors in peritoneal dialysis patients: findings from a retrospective study
Oral disease may be increased in people with end-stage renal disease and associated with inflammation, cardiovascular disease, and mortality. Moreover, oral disease may be essential to decide the prognosis of peritoneal dialysis (PD) patients. However, only a few reports have explored the effects of dental care (DC) on cardiovascular diseases and mortality in PD patients. Thus, we aimed to investigate the association of DC with the prognosis of PD patients.
Featured article: Aortic arch calcification affects causes of death in patients on hemodialysis: a retrospective cohort study
Aortic arch calcification (AAC) is a well-known risk factor for death in patients on hemodialysis (HD); however, the causes of death among them have not been well studied. The study aimed to investigate the distribution of causes of death and long-term prognosis among different degrees of AAC in HD patients.
Articles
-
-
An exploratory clinical trial on the efficacy and safety of glucagon-like peptide-1 receptor agonist dulaglutide in patients with type 2 diabetes on maintenance hemodialysis
-
Renal health benefits of sustainable diets in Japan: a review
-
Ethical principles of renal therapy rationing in Senegal
-
Repeated streptococcal peritoneal dialysis-related peritonitis following stomatitis and gingival bleeding: a case report
2019
Thematic series
Official Guideline and Registry Data of Renal Replacement Therapy
Upcoming conferences
The 67th Annual Meeting of the Japanese Society for Dialysis Therapy
1-3 July 2022, Pacifico Yokohama
The 33rd Annual Meeting of the Japan Society for Blood Purification Critical Care
7-8 October 2022, Juroku Plaza
The 25th Annual Meeting of Japan Academy of Nephrology Nursing
The 7th Asian Nephrology Nursing Symposium
15-16 October, 2022, Nagoya Congress Center
The 16th Annual Meeting of the Japanese Society of Nephrology and Pharmacotherapy
29-30 October 2022, DEJIMA MESSE NAGASAKI
The 28th Annual Meeting of the Japanese Society for Peritoneal Dialysis
26-27 November 2022, Okayama Convention Center
The 43rd Japanese Society for Pediatrics Renal Failure
8-9 December 2022, Ochanomizu Sola City
The 56th Annual Meeting of Japanese Society for Clinical Renal Transplantation
10-12 February 2023, The Okura Tokyo
The 13th Annual Meeting of the Japanese Society of Renal Rehabilitation
17-19 March 2023, Omiya Sonic City Hall
The 68th Annual Meeting of the Japanese Society for Dialysis Therapy
16-18 June 2023, KCC: Kobe International Convention Center
The 69th Annual Meeting of the Japanese Society for Dialysis Therapy
7-9 June 2024, Pacifico Yokohama
Submit your manuscript
Please use the online submission system to submit your manuscript. For all enquiries about the journal, please access the site and click Contact Us.
Aims and scope
Renal Replacement Therapy is a peer-reviewed journal facilitating worldwide discussion of research and issues related to the study of renal replacement therapy.
RRT considers articles on all aspects of hemodialysis, peritoneal dialysis, blood purification, renal transplantation and regenerative medicine. In addition, the journal publishes content in wider fields such as chronic kidney disease (CKD), acute kidney injury (AKI), critical care medicine and intensive care, bone and mineral metabolism, anemia and iron metabolism, infection, cardiac disease, cerebral disease, diabetes mellitus, hypertension, nutrition, and related social issues. Contributions are encouraged from a global perspective across many disciplines.
Featured Collection: COVID-19-related Articles
The outbreak of novel coronavirus disease 2019 (COVID-19) led to a worldwide pandemic. Both failure to recover and poor prognoses for COVID-19 have been reported in patients with end-stage renal disease (ESRD) treated with renal replacement therapy and in the elderly. ESRD patients in Japan are one of the oldest populations in the world. Accordingly, we decided to launch the special collection on COVID-19 in RRT, the official journal of several academic societies with a focus on renal replacement therapy. We hope that this collection will support you in your own efforts.
Featured Collection: Official Guidelines and Registry Data of Renal Replacement Therapy
Our journal, entitled “Renal Replacement Therapy,” is the official publication of the following societies:
- Japanese Society for Dialysis Therapy (JSDT)
- Japanese Society for Clinical Renal Transplantation (JSCRT)
- Japanese Society for Peritoneal Dialysis (JSPD)
- Japan Society for Blood Purification in Critical Care (JSBPCC)
- Japanese Society of Renal Rehabilitation (JSRR)
- Japanese Society of Nephrology and Pharmacotherapy (JSNP)
- Japanese Society for Pediatric Renal Failure (JSPRF)
- Japan Academy of Nephrology Nursing (JANN)
Each of the societies above publishes valuable data based on clinical practice guidelines, statistical surveys, and epidemiological studies. This collection offers easy access to these resources. All papers in the collection are frequently accessed and highly cited. Moreover, the full text is published free of charge using an open journal CC-BY format. By pursuing this approach, our goal is to contribute as much as possible to the renal replacement therapy community while also responding to your interests.
Overcoming Language Barriers
If your manuscript could benefit from improvements to the English language, you should have your manuscript reviewed by someone who is fluent in English. For a collection of free resources to help with writing in English please visit here. If you would like professional help, we recommend our affiliates Nature Research Editing Service and American Journal Experts for help with English usage. BMC authors receive 10% off their first submission to either service. Please note that use of an editing service is neither a requirement nor a guarantee of publication.
Society affiliations
Renal Replacement Therapy is the official publication of the following societies:
- Japanese Society for Dialysis Therapy (JSDT)
- Japanese Society for Clinical Renal Transplantation (JSCRT)
- Japanese Society for Peritoneal Dialysis (JSPD)
- Japan Society for Blood Purification in Critical Care (JSBPCC)
- Japanese Society of Renal Rehabilitation (JSRR)
- Japanese Society of Nephrology and Pharmacotherapy (JSNP)
- Japanese Society for Pediatric Renal Failure (JSPRF)
- Japan Academy of Nephrology Nursing (JANN)
About the Editors
Dr. Takashi Shigematsu, Editor-in-Chief
Dr. Takashi Shigematsu is currently the emeritus professor of the department of nephrology at the Wakayama Medical University School of Medicine, Japan. He is now actively working as Director of Division of Nephrology and Clinical Research Center in Rinku General Medical Center. He is also a member of the International Society of Nephrology and the American Society of Nephrology.
His research interests focus on Mineral and Bone Disorder associated with chronic kidney disease (CKD) including vascular calcification, Senescence. Renal Anemia is another his major interest. In addition, he has been investigating and working in the fields of hemodialysis and vascular access, peritoneal dialysis, blood purification medicine in acute kidney injury, and kidney transplantation.
Prof. Masanori Abe, Deputy Editor
Professor and Chair of the Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
Prof. Abe also serves as the Chief Director of Blood Purification Center of Nihon University Itabashi Hospital. His professional interests include Nephrology and Renal Replacement Therapy.
Annual Journal Metrics
-
Speed
31 days to first decision for all manuscripts
42 days to first decision for reviewed manuscripts only
141 days from submission to acceptance
19 days from acceptance to publication
Usage
362,348 Downloads (2021)
13 Altmetric mentions